US Archives - Page 80 of 119 - European Medical Journal

Tamoxifen Reduces Recurrence for Patients with 'Good-Risk' Ductal Carcinoma In Situ: SABCS 2024

Findings, presented at SABCS 2024, support tamoxifen as an effective adjuvant therapy for reducing recurrence in women with “good-risk” DCIS who opt to skip RT.

Lessons from HIV/AIDS and COVID-19

The global challenges posed by HIV/AIDS and COVID-19 provide critical insights for managing future infectious disease outbreaks, according to a recent study by Anthony S Fauci and Gregory K Folkers.

Thin Melanomas: A Critical 0.8 mm Threshold

A recent cohort study involving 144,447 participants has found a crucial threshold in melanoma risk for tumors with a Breslow thickness between 0.8 and 1.0 mm.

A Guide to Chronic Hand Eczema

Chronic Hand Eczema (CHE) is a condition that can go under-recognized despite its significant impact on patients. With l.imited guidance..

EMJ

Prof Yoshiya Tanaka

Consultant Rheumatologist; Chairman, First Department of Internal Medicine; Dean, Graduate School of Medical Science, University of…

EMJ

Dr Judith A. Smith

Pediatric Rheumatologist; Associate Professor, Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, University of…

EMJ

Dr Isabelle Amigues

CEO, UnabridgedMD, Denver, Colorado, USA…

EMJ

Dr Arthur Kavanagh

Rheumatologist; Professor of Medicine; Director, Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology…

EMJ

Dr Christine Peoples

Director, Telerheumatology Program; Clinical Associate Professor of Medicine, Department of Medicine, Division of Rheumatology and…

EMJ

Prof Ian C. Chikanza

Consultant, Adult and Paediatric Rheumatology, Department of Rheumatology, Barts Arthritis Centre, Barts and The Royal London Hospital…